Pyxis Oncology (PYXS) Other Non-Current Assets (2020 - 2022)
Pyxis Oncology (PYXS) posted quarterly Other Non-Current Assets of $1.5 million for Q3 2022, up 1250.46% year-over-year from $109000.0 in Q3 2021, and little changed quarter-over-quarter from $1.5 million in Q2 2022.
Pyxis Oncology (PYXS) Other Non-Current Assets (2020 - 2022) Analysis & Trends
Pyxis Oncology (PYXS) has reported Other Non-Current Assets for 3 consecutive years, with $1.5 million the latest figure, recorded in Q3 2022.
- In Q3 2022, Other Non-Current Assets rose 1250.46% year-over-year to $1.5 million; the TTM figure through Sep 2022 stood at $1.5 million (up 1250.46% YoY), while the FY2021 annual figure was $109000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was little changed at $1.5 million in Q3 2022 per PYXS's latest filing, from $1.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.5 million in Q2 2022 and bottomed at $108000.0 in Q2 2021.
- Historically, Other Non-Current Assets has averaged $492125.0 across 3 years, with a median of $109000.0 in 2020.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets changed 0.0% — and 2022, when it soared 1262.96%.
- Pyxis Oncology's Other Non-Current Assets stood at $109000.0 in 2020, then changed by 0.0% to $109000.0 in 2021, then soared by 1250.46% to $1.5 million in 2022.
- Business Quant data shows PYXS's Other Non-Current Assets at $1.5 million in Q3 2022, $1.5 million in Q2 2022, and $449000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Pyxis Oncology | 198.37 Mn | 165.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 449,000.00 |
| Dec 31, 2021 | 109,000.00 |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 108,000.00 |
| Mar 31, 2021 | 109,000.00 |
| Dec 31, 2020 | 109,000.00 |